InsiderSignal.AI

InsiderSignal.ai

NRIX - Nurix Therapeutics, Inc.

Insider Sale by Ring Christine (GC)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

Yesterday, Ring Christine, serving as GC at Nurix Therapeutics, Inc. (NRIX), sold 3,214 shares at $16.65 per share, for a total transaction value of $53,498.00. Following this transaction, Ring Christine now holds 31,847 shares of NRIX.

This sale represents a 9.00% decrease in Ring Christine's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 30, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 30, 2026, meaning the disclosure happened on the same day as the trade.

Nurix Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Ring Christine

Ring Christine

GC

Christine Ring, Ph.D., J.D., is Chief Legal Officer and Chief Compliance Officer at Nurix Therapeutics, Inc. (NRIX), a role she has held since October 2023.[[1]](https://www.nurixtx.com/leadership/)[[3]](https://www.bloomberg.com/profile/person/18857138) She has also served as the company’s Secretary since March 2020 and General Counsel since September 2019.[[1]](https://www.nurixtx.com/leadership/)[[2]](https://qb3.berkeley.edu/news/an-interview-with-professional-in-residence-christine-ring-thriving-at-the-interface/) In these capacities, she oversees legal matters, compliance, intellectual property protection, licensing transactions, capital raising, and transitions from private to public companies.[[1]](https://www.nurixtx.com/leadership/) Prior to Nurix, Dr. Ring was Senior Vice President, Legal at Dermira, Inc., a biotechnology company focused on medical dermatology, and Senior Vice President of Technology, Strategy & Licensing at Amyris, Inc., specializing in renewable fuels and specialty chemicals.[[1]](https://www.nurixtx.com/leadership/) She holds an A.B. in Biophysics from the University of California, Berkeley, a Ph.D. in Pharmaceutical Chemistry from the University of California, San Francisco, and a J.D. from the University of California, Hastings College of the Law.[[1]](https://www.nurixtx.com/leadership/) Dr. Ring is an active member of the California Bar.[[5]](https://apps.calbar.ca.gov/attorney/Licensee/Detail/183952) Recently, as a corporate insider and General Counsel, she reported trading common shares of Nurix Therapeutics.[[4]](https://longbridge.com/en/news/270220010)

View full insider profile →

Trade Price

$16.65

Quantity

3,214

Total Value

$53,498.00

Shares Owned

31,847

Trade Date

Thursday, April 30, 2026

1 days ago

SEC Filing Date

Thursday, April 30, 2026

HEALTHCAREBIOTECHNOLOGY

Discussion

Sign in to join the discussion.
Loading comments…
View news mentioning NRIX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/6081555

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime